Diclofenac Sodium Extended Release
Links shared publicly online about this topic
FDA accepts Eisai's NDA for rabeprazole sodium extended-release 50 mg
news-medical.net — “Eisai Inc. (Headquarters: Woodcliff Lake, NJ; Chairman and CEO: Hajime Shimizu), a U.S. subsidiary of Eisai Co., Ltd. (Headquarters: Tokyo; President and CEO: Haruo Naito) today announced that the U.S. Food and Drug Administration has accepted Eisai's New Drug Application for rabeprazole sodium extended-release 50 mg for the healing and maintenance of healing of erosive gastroesophageal reflux disease, and for the treatment of symptomatic GERD.” View full resource at news-medical.net
Most Recently Shared on June 3, 2010 at 5:13 am By:
Oncology News: FDA accepts Eisai's NDA for rabeprazole sodium extended-release 50 mg: Eisai Inc. (Headquarters: Wo... http://bit.ly/ak6CdD
FDA issues Complete Response Letter for approval of Eisai's rabeprazole sodium extended-release capsules
news-medical.net — “Eisai announced today that the company received a Complete Response Letter from the United States Food and Drug Administration (FDA) regarding the New Drug Application (NDA) of rabeprazole sodium extended-release capsules, 50 mg, an investigational proton pump inhibitor (PPI) under review for the healing and long-term maintenance of healing and symptom resolution of erosive gastroesophageal reflux disease (GERD), and for the treatment of daytime and nighttime heartburn and other symptoms of non-” View full resource at news-medical.net
Most Recently Shared on February 2, 2011 at 9:10 am By:
Oncology News: FDA issues Complete Response Letter for approval of Eisai's rabeprazole sodium extended-release c... http://bit.ly/hrM4wt
News From Annals Of Internal Medicine, March 2, 2010
medicalnewstoday.com — “1. Early Release: Decreasing U.S. Population Sodium Intake Could Prevent Heart Attacks, Extend Lives, and Save Billions of Dollars in Health Care Costs: Collaboration with Food Industry May Hel” View full resource at medicalnewstoday.com
Most Recently Shared on March 2, 2010 at 4:11 pm By:
News From Annals Of Internal Medicine, March 2, 2010 http://mnt.to/3yjS #cardiovascular
Major Study Shows That Lescol(R) XL, A Statin From Novartis, Improves Post-operative Cardiac Outcomes In Patients Undergoing Vascular Surgery
medicalnewstoday.com — “Patients undergoing vascular surgery treated perioperatively with lescol® xl (fluvastatin sodium extended-release tablets) showed a significant improvement in postoperative cardiac outcome wit” View full resource at medicalnewstoday.com
Most Recently Shared on September 6, 2009 at 10:14 am By:
Major Study Shows That Lescol(R) XL, A Statin From Novartis, Improves Post-operative Cardiac Outcomes In Patient.. http://bit.ly/RIdDC
Psychiatry Medical News about Schizotypal Personality Disorder
mdlinx.com — “Drug interaction between carbapenems and extended-release divalproex sodium in a patient with schizoaffective disorder” View full resource at mdlinx.com
Most Recently Shared on April 26, 2010 at 8:23 pm By:
Drug interaction between carbapenems and extended-release divalproex sodium in a patient with schizoaffective ... http://bit.ly/bgbcGf #PSY
FDA approves Unichem's generic treatment against seizures - Related Stories - AANP SmartBrief
smartbrief.com — “The FDA authorized Unichem Laboratories to launch extended-release divalproex sodium, a generic tablet for seizures. The approval covers doses of 125, 250 and 500 milligrams. ” View full resource at smartbrief.com
Most Recently Shared on April 8, 2011 at 3:12 pm By:
FDA approves Unichem's generic #treatment against #seizures. http://sbne.ws/r/7d10 #nurse #pharm #PCP #PSY #neuro
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
News-Medical.Net
Stay up to date with the latest Oncology news and research via News-Medical.Net
-
News-Medical.Net
Stay up to date with the latest Oncology news and research via News-Medical.Net
-
MNT Cardiovascular
The latest cardiovascular news published daily. Articles from research centers, universities and prestigious journals.
Advertisement

